Warning letter
Adamson Analytical Laboratories Inc: warning letter of Aug 2, 2016
FDA warning letter 479304 · Los Angeles District Office
Key facts
| Reference number | 479304 |
|---|---|
| Company | Adamson Analytical Laboratories Inc |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Aug 2, 2016 |
| Posted date | Aug 8, 2016 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 211.68(b), 211.160(b) |
| Inspection city | Corona |
| Inspection ZIP | 92879 |
| Inspection start date | Aug 4, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: